Weight-Loss Injections
Retatrutide is a new weight-loss injection made by Eli Lilly. The drug leads to an average of 24% weight loss and may be available by 2028.
Current Health
Phase 3 trial: survodutide produced up to 16.6% weight loss in 76 weeks. How it compares to Mounjaro, Wegovy, and Wegovy 7.2 mg.
Wegovy compatibility
You can take Wegovy with rheumatoid arthritis. Find out how it interacts with RA medications and why weight loss may improve disease activity.
Wegovy compatibility
You can take Wegovy with chronic kidney disease. Find out which stages are safe, how to monitor, and why it may protect kidney function.
Wegovy compatibility
You can take Wegovy after a gastric band, but the combination needs medical supervision. Find out what to expect from your bariatric team and GP.
Wegovy compatibility
Wegovy is safe to take with fibromyalgia. What the evidence shows on weight loss, pain, and fatigue, plus practical guidance for managing both.
Mounjaro compatibility
Mounjaro isn't recommended in pregnancy. UK guidance, the evidence on inadvertent exposure, and how to plan stopping safely before conceiving.
Wegovy compatibility
Wegovy and pregnancy: UK guidance says stop two months before trying to conceive. What the evidence shows and how to plan it safely.
Weight-loss medications
Use our free GLP-1 calorie calculator to get a daily calorie and protein target, plus how to reach it without counting using the balanced plate.
Weight Loss Programmes
Compare Second Nature vs Bolt Pharmacy for weight-loss injections. See pricing, support levels, and which approach suits your Mounjaro or Wegovy goals.
As seen on
As seen on